BONUS EPISODE: Pandemic Perspectives with Katrine Bosley
Over the next several weeks Distillations will be talking to people who have special insight into the coronavirus crisis—biomedical researchers, physicians, public health experts, and historians.
In this episode our producer Rigberto Hernandez talks with Katrine Bosley, who has worked in the biotech industry for more than 30 years. Until recently she was the CEO of Editas Medicine, a company that focuses on a gene-editing technology known as CRISPR. She’s now on the board of the Massachusetts Eye and Ear Hospital and is advising the facility on its quest to create a COVID-19 vaccine. She tells us how CRISPR can be used to make faster diagnostic tests and how the hospital in Boston is creating a vaccine using a gene therapy method.
“One of the things that’s important for all of us competing against this virus is to have a lot of technologically different strategies to try to make a vaccine.”